Pingtan Wenzhou Ruiji Investment Partnership Enterprise and Zhuzhou Wenzhou Junzhe Venture Capital Partnership Enterprise (L.P.) managed by Shanghai Wenzhou Investment Management Co., Ltd. completed the acquisition of 4.94% stake in Minova Pharma from Hefei Lifeon Pharmaceutical Co., Ltd. for approximately CNY 32.1 million.
August 12, 2022
Share
Pingtan Wenzhou Ruiji Investment Partnership Enterprise and Zhuzhou Wenzhou Junzhe Venture Capital Partnership Enterprise (L.P.) managed by Shanghai Wenzhou Investment Management Co., Ltd. agreed to acquire a 4.94% stake in Minova Pharma from Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE:003020) for approximately CNY 32.1 million on January 22, 2022. Pingtan Wenzhou Ruiji Investment Partnership Enterprise will acquire 4.7075% stake and Pingtan Fanrun Enterprise Management Partnership Enterprise will acquire 0.2307% stake. The transaction is approved by the board of Hefei Lifeon. On March 29, 2022, due to the new crown epidemic and other reasons, Pingtan Wenzhou Ruiji Investment Partnership Enterprise failed to complete the filing with the Asset Management Association of China, and plans to complete the filing with the Asset Management Association of China before May 31, 2022. As of June 1, 2022, Pingtan Wenzhou Ruiji Investment Partnership Enterprise failed to complete the filing with the Asset Management Association of China, due to the new crown epidemic and other reasons and plans to complete the filing with the Asset Management Association of China before August 31, 2022.
Pingtan Wenzhou Ruiji Investment Partnership Enterprise and Zhuzhou Wenzhou Junzhe Venture Capital Partnership Enterprise (L.P.) managed by Shanghai Wenzhou Investment Management Co., Ltd. completed the acquisition of 4.94% stake in Minova Pharma from Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE:003020) for approximately CNY 32.1 million on August 12, 2022.
Hefei Lifeon Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceutical preparations and active pharmaceutical ingredients (APIs). The Company is also engaged in the wholesale and retailing of pharmaceuticals and medical devices. The Company's main products involve cardiovascular drugs, digestive system drugs and skin topical drugs.
Pingtan Wenzhou Ruiji Investment Partnership Enterprise and Zhuzhou Wenzhou Junzhe Venture Capital Partnership Enterprise (L.P.) managed by Shanghai Wenzhou Investment Management Co., Ltd. completed the acquisition of 4.94% stake in Minova Pharma from Hefei Lifeon Pharmaceutical Co., Ltd. for approximately CNY 32.1 million.
HEFEI LIFEON PHARMACEUTICAL CO., LTD. 
